Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:24-32, doi:10.1016/j.jacc.2008.02.066
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Online Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, S. H.
Right arrow Articles by Tsimikas, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Choi, S. H.
Right arrow Articles by Tsimikas, S.

Relationship Between Biomarkers of Oxidized Low-Density Lipoprotein, Statin Therapy, Quantitative Coronary Angiography, and Atheroma Volume

Observations From the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) Study

Seung Hyuk Choi, MD*,§, Andrew Chae, BS§, Elizabeth Miller, BS§, Michael Messig, PhD{dagger}, Fady Ntanios, PhD{dagger}, Anthony N. DeMaria, MD, MACC§, Steven E. Nissen, MD, FACC*, Joseph L. Witztum, MD§ and Sotirios Tsimikas, MD, FACC§,*

* Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
{dagger} Pfizer Inc, New York, New York
{ddagger} Cleveland Clinic Foundation, Cleveland, Ohio
§ University of California–San Diego, San Diego, California.


Figure 1
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Statins and Lipid Parameters

The influence of statin therapy on lipid parameters. ApoB = apolipoprotein B-100; CI = confidence interval; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol.

 

Figure 2
View larger version (23K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Statins and Biomarkers

The influence of statin therapy on plasma oxidized low-density lipoprotein (OxLDL) biomarkers and high sensitivity C-reactive protein (CRP). apoB-IC = apolipoprotein B-100 immune complexes; CI = confidence interval; IC/apoB = immune complexes per apolipoprotein B-100; Ig = immunoglobin; Lp(a) = lipoprotein (a); MDA = malondialdehyde; MDA/apoB = malondialdehyde epitopes per apolipoprotein B-100; OxPL/apoB = oxidized phospholipid epitopes per apolipoprotein B-100.

 

Figure 3
View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Atheroma Volume and Oxidation-Specific Epitopes

Locally weighted scatter plots showing the relationship between the percentage change in atheroma volume and the percentage change in OxPL/apoB, MDA/apoB, and Lp(a) in the 214 patients. In each plot, the solid line represents the point estimates and the dashed lines the 95% confidence intervals. Abbreviations as in Figure 2.

 

Figure 4
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Relationship of Lp(a) to Oxidation-Specific Epitopes

Spearman correlations between baseline levels of Lp(a) with OxPL/apoB and Lp(a) and MDA/apoB. Dashed lines represent the 95% confidence interval. RLU = relative light units; other abbreviations as in Figure 2.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement